ArticleJournal of experimental & clinical cancer research : CR2019

Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.

Leilei He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.